Crystal Clear? The 2022 NICE Guideline for the Diagnosis and Management of Gout
Gout, Urate, and Crystal Deposition Disease · 2023
DOI: 10.3390/gucdd1010002 ↗Kurz gefasst
Leitlinie in der Zeitschrift Gout, Urate, and Crystal Deposition Disease, 2023. Verfasst von Chanaka Dahanayake und 2 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gout is the most common inflammatory arthritis and causes significant pain and disability [...]
Zitieren
APA
Dahanayake, C., Jordan, K. M., & Roddy, E. (2023). Crystal Clear? The 2022 NICE Guideline for the Diagnosis and Management of Gout. Gout, Urate, and Crystal Deposition Disease. https://doi.org/10.3390/gucdd1010002
Vancouver
Dahanayake C, Jordan KM, Roddy E. Crystal Clear? The 2022 NICE Guideline for the Diagnosis and Management of Gout. Gout, Urate, and Crystal Deposition Disease. 2023. doi:10.3390/gucdd1010002
BibTeX
@article{Dahanayake2023,
author = {Dahanayake, Chanaka and Jordan, Kelsey M. and Roddy, Edward},
title = {Crystal Clear? The 2022 NICE Guideline for the Diagnosis and Management of Gout},
journal = {Gout, Urate, and Crystal Deposition Disease},
year = {2023},
doi = {10.3390/gucdd1010002}
}
EUVIMED